The drug, suzetrigine, will be sold under the brand name Journavx and is the first new class of pain medicine approved in ...

A non-opioid pain medication made by Vertex Pharmaceuticals has received approval for adults from the Food and Drug ...

The FDA has approved Journavx, a pain medication, offering a safer alternative to opioids. Learn about its benefits and side ...

Journavx (suzetrigine) is said to reduce pin by "targeting a pain-signaling pathway involving sodium channels in the ...

The new non-opioid drug has been approved for the treatment of severe pain, such as that following surgery or an injury.

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...

The prescription pills, sold under the brand name Journavx and made by Vertex Pharmaceuticals, are taken twice a day and ...

Patients seeking an opioid-free way to handle pain experienced in the short-term will soon have a new option.

Analyst is bullish on Vertex Pharmaceuticals, citing FDA approval for JOURNAVX and strong earnings growth potential in 2025.

The U.S. Food and Drug Administration has approved Vertex Pharmaceuticals' drug to treat acute pain, the health regulator ...

The Food and Drug Administration has approved a first-of-its-kind non-opioid pain medication, providing a new option for ...